title: What is your reasonable expectation of success in obtaining pharmaceutical or biotechnology patents having nonobvious claimed inventions that the courts will uphold? An overview of obviousness court decisions.
abstract: This article explores the legal basis for establishing the nonobviousness of patent claims in the life sciences fields of technology drawn from the guidance provided in published decisions of the U.S. Patent and Trademark Office's Patent Trial and Appeal Board, federal district courts, the Federal Circuit Court of Appeals, and the U.S. Supreme Court. Our analysis, although equally applicable to all disciplines and technologies, focuses primarily on decisions of greatest import affecting patents in the fields of pharmaceutical chemistry and biotechnology.
authors.affiliation: Oblon, Spivak, McClelland, Maier & Neustadt, LLP, Alexandria, Virginia 22314.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Pereira
authors.affiliation: Oblon, Spivak, McClelland, Maier & Neustadt, LLP, Alexandria, Virginia 22314.
authors.forename: Stephen G
authors.initials: SG
authors.lastname: Kunin
mesh_terms: D001709:Biotechnology / Q000331:legislation & jurisprudence*; D002626:Chemistry, Pharmaceutical / Q000331:legislation & jurisprudence*; D017408:Guidelines as Topic; D062069:Inventions / Q000331:legislation & jurisprudence*; D010330:Patents as Topic; D014481:United States